CFIR Domain | Barrier Definition | Illustrative examples | All survey responses, NÌý= 9714 n1 (% of N)a n2 (% of n1)b |
---|---|---|---|
External Factors | Political, economic, social, technological, legal, and other environmental factors | Ìý | 3826 (39.4%) |
Social | Communities are non-accepting and/or resistant to the intervention | • Vaccine hesitancy • Community fatigue given repeated campaigns, misaligned priorities • Lack of information | 1695 (44.3%) |
Economic | Insufficient revenue sources | • Limited economic resources | 1170 (30.6%) |
Political | Policymaker disinterest or resistance, limited windows of opportunity within the political climate, political structure non-conducive to coordinated action | • Low political will • Insecurity and conflict | 1115 (29.1%) |
Technological | Slow or limited advances of technologies used in implementing program activities | • Technological and infrastructural challenges affecting vaccine supply and surveillance | 626 (16.4%) |
Other | Challenges related to physical and human geography | • Geographical inaccessibility • Population migration | 817 (21.4.0%) |
Process of activities | How activities were implemented | Ìý | 2144 (22.1%) |
Executing | Failing to carry out activities according to plan | • Lack of accountability mechanisms • Environmental disruptions to program implementation • IPV supply challenges | 1213 (56.6%) |
Engaging | Difficulty attracting and involving appropriate stakeholders in implementation | • Difficulty identifying appropriate stakeholders to engage given diverse administrative structures, cultural norms • Community mistrust | 915 (42.7%) |
Reflecting & Evaluating | Difficulty monitoring program progress and quality, including lack of regular debriefing about progress and experience | • Lack of supervision • Lack of formal processes for analyzing monitoring data and adapting plans accordingly | 803 (37.5%) |
Planning | Implementation schemes/methods not planned in advance, or poor quality of such methods | • Poor quality enumeration • Difficulty in planning large-scale changes, e.g. the switch from tOPV to bOPV | 758 (35.4%) |
Characteristics of individuals | Characteristics of individuals within an organization involved in polio eradication activities | Ìý | 1773 (18.3%) |
Knowledge | Knowledge and beliefs about the activity - individuals did not have positive attitude toward the program, were unfamiliar with facts, truths and principles related to the intervention | • Misconceptions about the vaccine and its effects • Lack of awareness of vaccine benefits | 1121 (63.2%) |
Stage of Change | How likely (or not) the individual is to provide skilled, enthusiastic and sustained support of the program throughout the different stages of implementation | • Health worker fatigue resulting from campaign/vaccine fatigue from the communities | 566 (31.9%) |
Perception of organization | Poor perception of the organization and degree of commitment to the organization | • Temporary status of some frontline workers affecting commitment to organizational goal | 419 (23.6%) |
Self-efficacy | Lack of belief in one’s own abilities to execute required courses of action | • Health workers’ lack of understanding of the program, what’s expected of them | 394 (22.2%) |
Organizational characteristics | Factors related to the organization(s) supporting implementation | Ìý | 1076 (11.1%) |
Structure | The age, social architecture, and size of an organization led to challenges | • Shifting structure of global partnership • Understaffing and shifting roles of staff | 236 (21.9%) |
Networks | The nature and quality of formal and informal communication within an organization led to challenges | • Limited communication channels between extension workers, program leads • Challenges related to dissemination of strategy from central to peripheral level, including securing buy-in | 439 (40.8%) |
Culture | The norms, values, and operating assumptions of an organization led to challenges | • Priorities dictated by managers • Limited voice given to field workers to propose adaptations | 349 (32.4%) |
Implementation Climate | Limited capacity for change, the receptivity of the team to the proposed intervention, the relative priority of project, organizational goals, incentive and rewards, etc. led to challenges | • Lack of consensus on program strategy • Waning prioritization of polio among some stakeholders | 398 (37.0%) |
Implementation Readiness | Lack of leadership engagement, limited available resources and poor access to knowledge and information led to challenges | • IPV shortage • Chronic underfunding of the health system | 469 (43.6%) |
Program characteristics | Activities conducted to enable implementation, including technologies adopted | Ìý | 895 (9.2%) |
Intervention Source | Perception of whether the intervention was developed internally or externally led to challenges | • Imbalance between global and national priorities • Community distrust of western intervention | 276 (30.8%) |
Evidence | Perception of the quality and validity of the evidence did not support belief that the intervention would have the desired outcomes | • Concerns about relative effectiveness of OPV and IPV | 302 (33.7%) |
Relative Advantage | Perception that there was another, better approach | • Concern that polio program is run in parallel to (and at expense of) routine immunization | 200 (22.3%) |
Adaptability | The activity was not adapted, tailored or refined to meet local needs | • Lack of understanding of community norms to guide adaptation of implementation activities | 361 (40.3%) |
Trialability | No ability to test on a small scale and reverse course if warranted | • Perception of polio program asÌýtoo big to fail even in the face of coordination and implementation failure affecting certain activities | 101 (11.3%) |
Complexity | Perceived difficulty of implementation reflected by its duration, scope, radicalness, disruptiveness, centrality, intricacy, and number of steps required | • Difficulty sustaining the cold chain in hard-to-reach areas • Health worker and community fatigue | 284 (31.7%) |
Design Quality & Packaging | Difficulty arising from how the intervention is bundled, presented, and assembled | • Challenges related to use of injectable vaccine (IPV) • Vaccine wastage due to how IPV and OPV were packaged, especially in hard-to-reach areas | 162 (18.1%) |
Cost | Cost of intervention and its implementation, including investment, supply, and opportunity costs | • Difficulty financing program functions previously supported by donors • High cost of implementation in hard-to-reach areas | 252 (28.2%) |